Predictive implications of decreased CA19‐9 at 8 weeks during nab‐paclitaxel plus gemcitabine for the induction of second‐line chemotherapy for patients with advanced pancreatic cancer

JOURNAL ARTICLE published December 2020 in Cancer Reports

Authors: Kiyotsugu Iede | Terumasa Yamada | Ryo Kato | Masami Ueda | Yujiro Tsuda | Shinsuke Nakashima | Katsuya Ohta | Jin Matsuyama | Masakazu Ikenaga | Shusei Tominaga